인세리브로 Main menu
All Menu
From The Mind Come Drugs of the Future
Read 1,050
관리자 2022-12-08 14:44
Publication: Nature Chemical Biology
Date of Publication: DECEMBER 2018
Authors: Ryoji Suno, Sangbae Lee, Brian K. Kobilka, Nagarajan Vaidehi, and Takuya Kobayashi
DOI: https://doi.org/10.1038/s41589-018-0152-y
Human muscarinic receptor M2 is one of the five subtypes of muscarinic receptors belonging to the family of G-protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype-selective ligands against one of the five muscarinic receptors. We report high-resolution structures of a thermostabilized mutant M2 receptor bound to a subtype-selective antagonist AF-DX 384 and a nonselective antagonist NMS. The thermostabilizing mutation S110R in M2 was predicted using a theoretical strategy previously developed in our group. Comparison of the crystal structures and pharmacological properties of the M2 receptor shows that the Arg in the S110R mutant mimics the stabilizing role of the sodium cation, which is known to allosterically stabilize inactive state(s) of class A GPCRs. Molecular dynamics simulations reveal that tightening of the ligand–residue contacts in M2 receptors compared to M3 receptors leads to subtype selectivity of AF-DX 384.